S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 26.33 CNY -5.01% Market Closed
Market Cap: 17.5B CNY
Have any thoughts about
Shandong Pharmaceutical Glass Co Ltd?
Write Note

Shandong Pharmaceutical Glass Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shandong Pharmaceutical Glass Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Additional Paid In Capital
ÂĄ2.7B
CAGR 3-Years
43%
CAGR 5-Years
24%
CAGR 10-Years
16%
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Additional Paid In Capital
ÂĄ2.7B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Autobio Diagnostics Co Ltd
SSE:603658
Additional Paid In Capital
ÂĄ4.1B
CAGR 3-Years
0%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Additional Paid In Capital
ÂĄ4.4B
CAGR 3-Years
-1%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Additional Paid In Capital
ÂĄ1.3B
CAGR 3-Years
-6%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Intco Medical Technology Co Ltd
SZSE:300677
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
-9%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Shandong Pharmaceutical Glass Co Ltd
Glance View

Market Cap
17.5B CNY
Industry
Health Care

In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.

Intrinsic Value
45.92 CNY
Undervaluation 43%
Intrinsic Value
Price
S

See Also

What is Shandong Pharmaceutical Glass Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
2.7B CNY

Based on the financial report for Sep 30, 2024, Shandong Pharmaceutical Glass Co Ltd's Additional Paid In Capital amounts to 2.7B CNY.

What is Shandong Pharmaceutical Glass Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
16%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Shandong Pharmaceutical Glass Co Ltd have been 43% over the past three years , 24% over the past five years , and 16% over the past ten years .

Back to Top